CME Group (NASDAQ:CME) Upgraded at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME - Get Free Report) was upgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a note issued to investors on Thursday,Benzinga reports. The firm presently has a $300.00 price target on the financial services provider's stock, up from their prior price target of $266.00. Deutsche Bank Aktiengesellschaft's price target would indicate a potential upside of 12.02% from the company's current price.

CME has been the topic of a number of other reports. TD Cowen lifted their price objective on shares of CME Group from $281.00 to $288.00 and gave the company a "hold" rating in a research note on Wednesday, October 8th. Raymond James Financial dropped their price target on shares of CME Group from $309.00 to $307.00 and set an "outperform" rating on the stock in a research note on Monday, October 13th. Oppenheimer boosted their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. UBS Group dropped their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating on the stock in a research note on Monday, September 8th. Finally, Weiss Ratings reiterated a "buy (b)" rating on shares of CME Group in a research note on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $286.14.

CME Group Trading Down 0.3%

NASDAQ CME opened at $267.81 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $96.51 billion, a PE ratio of 25.93, a P/E/G ratio of 6.18 and a beta of 0.41. CME Group has a one year low of $213.94 and a one year high of $290.79. The firm's fifty day moving average is $266.67 and its two-hundred day moving average is $271.45.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating analysts' consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.68 earnings per share. Analysts expect that CME Group will post 10.49 earnings per share for the current year.

Insider Activity at CME Group

In related news, Director William R. Shepard acquired 262 shares of the firm's stock in a transaction that occurred on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares in the company, valued at approximately $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the business's stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 in the last ninety days. Corporate insiders own 0.30% of the company's stock.

Institutional Trading of CME Group

Institutional investors and hedge funds have recently modified their holdings of the business. Jessup Wealth Management Inc boosted its stake in CME Group by 0.5% during the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider's stock valued at $2,197,000 after acquiring an additional 36 shares during the last quarter. First Horizon Advisors Inc. boosted its stake in CME Group by 0.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider's stock valued at $1,453,000 after acquiring an additional 36 shares during the last quarter. Great Lakes Advisors LLC boosted its stake in CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider's stock valued at $441,000 after acquiring an additional 37 shares during the last quarter. MBM Wealth Consultants LLC lifted its position in shares of CME Group by 2.7% in the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider's stock worth $392,000 after buying an additional 37 shares during the last quarter. Finally, Beaumont Financial Advisors LLC lifted its position in shares of CME Group by 2.0% in the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider's stock worth $538,000 after buying an additional 38 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.